AI assistant
Sending…
MetaVia Inc. — Director's Dealing 2023
Nov 2, 2023
34919_dirs_2023-11-02_d3bf6665-cd20-4708-82d8-0c1f0db3b72c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: NeuroBo Pharmaceuticals, Inc. (NRBO)
CIK: 0001638287
Period of Report: 2023-11-01
Reporting Person: Tursi James Patrick (Director)
More from MetaVia Inc.
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 18
Interim / Quarterly Report
2026
May 14
Regulatory Filings
2026
May 14
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 27
Proxy Solicitation & Information Statement
2026
Apr 27
Regulatory Filings
2026
Apr 10
Regulatory Filings
2026
Apr 7
Regulatory Filings
2026
Apr 3